Avelumab (renal cell carcinoma): Solution concentrate for I.V. infusion 200 mg in 10 mL; Bavencio® Page last updated: 2 July 2021 Public Summary Document (PSD) March 2021 PBAC Meeting - (PDF 1727KB) Public Summary Document (PSD) March 2021 PBAC Meeting - (Word 714KB)